title: Local low-dose of soluble GM-CSF significantly augments an immune response against tumour antigens in man.
authors.affiliation: Department of Oncology, Karolinska Hospital, Stockholm, Sweden. hme@rah.ks.se
authors.forename: H
authors.initials: H
authors.lastname: Mellstedt
authors.forename: J
authors.initials: J
authors.lastname: Fagerberg
authors.forename: A
authors.initials: A
authors.lastname: Osterborg
mesh_terms: D000276:Adjuvants, Immunologic; D000818:Animals; D019496:Cancer Vaccines / Q000276:immunology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000276:immunology*; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy
chemical_list: D000276:Adjuvants, Immunologic; D019496:Cancer Vaccines; D016178:Granulocyte-Macrophage Colony-Stimulating Factor